ELCRX
Price
$41.70
Change
-$0.08 (-0.19%)
Updated
Jun 2 closing price
Net Assets
462.37M
GFACX
Price
$73.86
Change
-$0.24 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

ELCRX vs GFACX

Header iconELCRX vs GFACX Comparison
Open Charts ELCRX vs GFACXBanner chart's image
ELCRX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
ELCRX vs. GFACX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCRX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. ELCRX (462M). ELCRX (0.00) and GFACX (0.00) have matching dividends . ELCRX was incepted earlier than GFACX: ELCRX (17 years) vs GFACX (25 years). GFACX (1.35) and ELCRX (1.29) have similar cost to investors . GFACX is a more actively managed with annual turnover of: 32.00 vs. ELCRX (20.00). GFACX has a lower initial minimum investment than ELCRX: GFACX (250) vs ELCRX (1000). GFACX annual gain was more profitable for investors over the last year : 12.09 vs. ELCRX (6.75). GFACX return over 5 years is better than : 14.79 vs. ELCRX (13.59).
ELCRXGFACXELCRX / GFACX
Total Expense Ratio1.291.3596%
Annual Report Gross Expense Ratio1.291.3596%
Fund Existence17 years25 years-
Gain YTD9.08610.10490%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.7512.0956%
Returns for 3 years37.3944.3684%
Returns for 5 years13.5914.7992%
Returns for 10 years91.3088.17104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVR10.250.50
+5.13%
Chicago Rivet & Machine Co
WHG16.660.65
+4.06%
Westwood Holdings Group
EXPE226.37-2.00
-0.88%
Expedia Group
GPI308.32-3.19
-1.02%
Group 1 Automotive
ETON27.34-1.34
-4.67%
Eton Pharmaceuticals